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a  b  s  t  r  a  c  t
IgG  avidity  assays  have  been  developed  for several  parasitic  diseases  although  there  are  no  researches
focused  in strongyloidiasis  diagnosis.  Deﬁnitive  diagnosis  of  strongyloidiasis  is  based  on  the  presence
of  Strongyloides  larvae  in stool,  but majority  of  cases  involve  low  and  irregular  larval  output.  While  lim-
itations  of serological  assays  for strongyloidiasis  are  well  known,  characteristics  of persons  who  are
misdiagnosed  based  on negative  coproparasitological  tests  have  been  little  explored.  The  aim  of the
present  study  was  to  evaluate  the  use  of  IgG  avidity  to detect  patients  with  active  strongyloidiasis  and
to  characterize  sources  of  disagreement  between  serology  and  coproparasitology.  A total  of  80 serum
samples  was  analyzed,  40  from  patients  with  Strongyloides  larvae  in  stool (G1)  and  40  from  individ-
uals  with  negative  coproparasitology,  but positive  serology  (G2).  Serum  samples  were  analyzed  in  an
indirect  IgG  avidity  ELISA  using  urea  6 M in  serial  double  dilutions  from  1:80 to 1:2560.  Avidity  index
(AI)  was  calculated  to  each  serum  dilution  and  analyzed  as  screening  AI (serum  dilution  of 1:160)  or
mean  AI  of  different  serum  dilutions  that  had  a positive  result.  Statistical  analyzes  were  performed  by
Mann–Whitney’s  (U)  and  Fisher’s  exact  tests.  At  screening  dilution,  median  of AI  was  68% in G1 and  88%
in  G2  (P  <  0.0001),  whereas  median  of  mean  AI in  G1 was  72%  and  in  G2  94%  (P <  0.0001),  but  there  was
no  signiﬁcant  differences  between  both  AI in  each  patient  group.  A  cut  off value  established  at AI of  75%
demonstrated  a signiﬁcant  difference  between  groups,  with  G1  sera  showing  AI < 75%  and  G2  sera  with
AI  >  75%  (P  < 0.0001).  In conclusion,  IgG  avidity  assays  may  distinguish  active  infection  with  Strongyloides
stercoralis  from  suspect  or  serologically  false  positive  cases.. Introduction
Strongyloidiasis, caused by the nematode Strongyloides ster-
oralis, is one of the major intestinal infections in humans with
orldwide distribution, especially in tropical and subtropical areas
1]. Clinical features of this disease are relatively non-speciﬁc
eading to diagnostic difﬁculties [2]. Deﬁnitive diagnosis of S. ster-
oralis infection relies mainly on demonstration of larval stages
n stool with a minimum of three samples analyzed. Neverthe-
ess, to achieve 100% of sensitivity seven fecal samples collected
n alternate days are required. However, since majority of cases
nvolves low and irregular larval output, negative parasitological
esults cannot be interpreted as absence of infection [3–5]. Thus,
irect diagnosis of strongyloidiasis is one of the most complicated
n parasitology [4]. As sensitivity of stool examination is highly
ariable and other demonstrative techniques are quite invasive,
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indirect diagnosis based on serology is widely used in addition to
the examination of stool specimens [5].
Several studies demonstrated that anti-L3 antibodies, using
homologous or heterologous antigens, can be detected in more than
80% of coprologically positive patients [6–10]. Those data showed
that enzyme-linked immunosorbent assay (ELISA) protocols are
helpful, with high sensitivity and speciﬁcity values, although dis-
tinction between infections with S. stercoralis from serologically
positive cases with negative coproparasitological tests cannot be
successfully established [3].
In these cases in which larvae could not be detected in stool
specimens, but serological tests remain positive, it is required a
novel approach to favor recognition and differentiation between
active infection with S. stercoralis and suspect cases or false positive
serological results. Thus, the use of alternative techniques to the
classic ELISA, such as antibody avidity assays, has been recently
proposed for other parasitic diseases [11–13].
Open access under the Elsevier OA license.It is known that avidity of antibodies increases with time after
antigen challenge and measurement of avidity has been used espe-
cially in cases when differentiation of recent and past infections is
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een useful in several parasitic diseases, including toxoplasmosis
14,15], hidatidosis [16], schistosomiasis [17], toxocariasis [12] and
eurocysticercosis [13].
Considering the complexity of parasitological diagnosis for
trongyloidiasis and the problem of deﬁning a cut-off to discern
urrent from past infection or cross-reacting antibodies, the aim of
his study was to explore the development of a reliable IgG avid-
ty test able to distinguish active infection with S. stercoralis from
uspect cases or false positive serological results.
. Materials and methods
.1. Patients
Serum samples were obtained from 80 patients admitted to
he Clinic Hospital of the Federal University of Uberlândia, State
f Minas Gerais, Brazil. Samples were divided into two  groups:
roup 1, 40 patients living in an endemic area and with conﬁrmed
erological and parasitological diagnosis of strongyloidiasis using
aermann [18] and Moraes [19] method, based on positive lar-
al thermo-hydrotropism and Lutz [20], a gravity sedimentation
echnique. Group 2, 40 individuals with negative coproparasitolog-
cal tests for strongyloidiasis in three stool samples as previously
entioned, but positive results in the serological test (ELISA)
sing antigen from Strongyloides species. This group comprises a
ommon routine problem in strongyloidiasis, then the diagnosis
an be complemented by immunologic techniques. Stool samples
ere collected in alternate days during a week avoiding problems
elated to possible intermittent shedding of larvae. Also, each of
he 240 samples was extensively examinated. Six slides for each
tool concentration technique were analyzed. The total number
f slides examinated was 2880. The use negative stool samples
nd serum positive in ELISA as comparators criteria may  assess
he utility of avidity approach in discriminating the groups. This
tudy received approval from the Research Ethics Committee of
he Universidade Federal de Uberlândia (UFU), State of Minas Gerais,
razil.
.2. Parasites
Strongyloides venezuelensis third-stage larvae (L3) were obtained
rom charcoal cultures of feces from experimentally infected rats
Rattus norvegicus–Wistar) at the State University of Campinas, São
aulo, Brazil. Fecal samples were mixed with equal parts of ground
ood charcoal, moistened with water, spread in uniform layers
n Petri dishes, and incubated at 28 ◦C for 72 h. Infective larvae
ere collected and concentrated using Rugai apparatus [21]. L3
arvae were washed 5 times in phosphate-buffered saline (PBS),
.01 mol/L, pH 7.2, and stored at −20 ◦C in PBS until use in antigen
reparation.
.3. Total saline extract from S. venezuelensis
For antigen preparation, S. venezuelensis ﬁlariform larvae
300,000) were resuspended in PBS (0.01 mol/L, pH 7.2) contain-
ng protease inhibitors cocktail (aprotinin 1 g/ml, benzamidine
 mM,  ethylenediaminetetracetic acid 1 mM,  leupeptin 2 g/ml,
nd phenyl methyl sulfonyl ﬂuoride 1 mM)  and disrupted in cycles
f freezing (1 min, −196 ◦C) and thawing/sonication (5 min, 40 kHz,
7 ◦C). After overnight incubation at 4 ◦C under gentle shaking, the
uspension was centrifuged at 12,400 × g for 30 min  at 4 ◦C and the
upernatant (saline extract, SE) was analyzed for protein content
22], distributed into aliquots and stored at −20 ◦C until use. Letters 139 (2011) 87– 92
2.4. Avidity ELISA
Preliminary experiments were carried out to determine the
optimal conditions for IgG avidity ELISA, through block titrations
of reagents (antigen, sera and conjugate), following the protocol
previously described by Manhani et al. [13], with minor mod-
iﬁcations. Brieﬂy, polystyrene microtitration plates were coated
with SE (5 g/mL in 0.06 mol/L carbonate bicarbonate buffer, pH
9.6) overnight at 4 ◦C and then washed three times with PBS
containing 0.05% Tween 20 (PBS-T). Serum samples diluted in
PBS-T (1:80, 1:160, 1:320, 1:640, 1:1280 and 1:2560) were added
in quadruplicate and incubated for 45 min  at 37 ◦C. Next, half
of the quadruplicate sera were treated with urea (6 M)  diluted
in PBS (PBS-U+), for 10 min  at room temperature (RT), and the
remaining sera were incubated with PBS-T for the same time, fol-
lowed by 3 washing steps as previously mentioned. Subsequently,
antibody enzyme conjugate (peroxidase-goat anti-human IgG, Fc
speciﬁc, Sigma Chemical Co., St. Louis, USA) diluted 1:2000 in
PBS-T was  added and plates were incubated for 45 min at 37 ◦C.
The assay was  developed by adding 0.03% hydrogen peroxide and
o-phenylenediamine (0.5 mg/mL in 0.1 mol/L citrate–phosphate
buffer, pH 5.5) for 15 min, followed by addition of H2SO4 (2 N) to
stop reaction. Optical densities (OD) were determined at 492 nm in
an ELISA reader. Three sera from healthy individuals without clini-
cal or epidemiologic data for strongyloidiasis were used as negative
controls.
IgG avidity was expressed as avidity index (AI), calculated based
on the screening serum dilution, following the formula: screen-
ing AI = (mean OD of urea-treated sera/mean OD urea-untreated
sera) × 100%. Alternatively, AI was  calculated for each dilution of
serum samples that had a positive result following the above for-
mula, and the average of the determinations of AIs obtained at
different serum dilutions was  calculated and expressed as the mean
AI, as previously proposed [23].
2.5. Avidity immunoblot
Protein components of SE were subjected to electrophoresis
under reducing conditions in 15% sodium dodecyl sulfate-
polyacrylamide gel [24] and then transferred onto nitrocellulose
membranes (0.45 m;  Sigma) [25]. Membrane strips were sub-
mitted to immunoblot reaction as previously described [14] with
reagents standardization. Strips were blocked for 2 h at RT with 5%
skim milk in PBS-T (PBS-TM), and washed with PBS-TM 1%. Then,
serum samples diluted 1:50 were added and incubated for 18 h at
4 ◦C. To estimate IgG avidity for each S. venezuelensis antigenic frac-
tion, each sample was tested on 2 strips. After sera incubation, one
strip was washed with PBS-T (6 times; 5 min  each) and the other
one with urea (6 M)  in PBS-TU+ (3 times with PBS-TU+ followed
by 3 times with PBS-T; 5 min  each). After, peroxidase-goat anti-
human IgG whole molecule (Sigma Chemical Co., St. Louis, USA)
diluted 1:1500 was  added and incubated for 1 h 30 min. Reactiv-
ity was  detected using 3,3′-diaminobenzidine tablets with metal
enhancer (Sigma Chemical Co., St. Louis, USA) and reaction was
stopped with distilled water.
Each strip was  analyzed based on recognition of antigenic frac-
tions by antibodies present in serum samples. Molecular mass
of each polipeptide was  estimated based on molecular markers
and ImageJ version 1.44 software (National Institutes of Health,
Bethesda, USA). Band proﬁles obtained for samples treated (U+)
and untreated (U−) were analyzed. Grayscale scanned images were
marked, and intensity of regions was calculated. Graphs with
intensity peak were generated and background was  eliminated.
Decrease in reactivity between U+ and U− was calculated according
to Aguado-Martínez et al. [11], with modiﬁcations. Four categories
were established for intensity of recognition: no detection, low,
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Fig. 1. Avidity index (AI) obtained from Strongyloides-speciﬁc IgG avidity ELISA in serologically positive patients with larval output (G1) or undetectable larvae in stool
specimens (G2). AI was  calculated for each serum dilution and the average of AI obtained from different serum dilutions that had a positive result is also shown. Data are
r tiles, and whiskers indicating the range of the data. Statistical signiﬁcance was  calculated



































IgG avidity ranges for Strongyloides in serologically positive patients with larval
output (G1) or undetectable larvae in stool specimens (G2).
Avidity index (AI) Patient groups
G1 (n = 39) G2 (n = 38)
Screening AIa
>75% 13 (33.3%) 32 (84.2%)*
<75% 26 (66.7%)* 6 (15.8%)
Mean AI n = 40 n = 40
>75% 10 (25.0%) 35 (87.5%)*
<75% 30 (75.0%)* 5 (12.5%)
a Screening AI was calculated based on the screening serum dilution of 1:160,
following the formula: AI = (mean OD of urea-treated sera/mean OD urea-untreated
sera) × 100%.
* Statistically signiﬁcant differences between groups (P < 0.0001, Fisher’s exact
test).
Fig. 2. Comparison between avidity indexes (AI) calculated as screening AI (serum
dilution of 1:160) and mean AI of different serum dilutions that had a positive result.
AIs  were obtained from Strongyloides-speciﬁc IgG avidity ELISA in serologically pos-epresented in box and whisker plot, with box indicating median and 25–75% percen
y  the Mann–Whitney test (*P < 0.05; ***P < 0.0001). n: number of samples analyzed
edium and high intensity. Avidity of IgG antibodies was estimated
ased on area of U− and U+ peaks and by visual comparison of the
ntensity before and after urea treatment. Two categories were des-
gnated: high decrease in intensity of recognition (− or +) assessed
s low avidity, whereas a low decrease (++ or +++) was assessed
s high avidity. Due to individual variation in antigen recognition,
nalysis focused on a ﬁnal classiﬁcation based on two bands at least.
f two or more bands were evaluated with high decrease in intensity
fter urea treatment, sample was considered with low IgG avidity,
hile if little change occurred in recognition of two  or more bands,
ample was classiﬁed with high IgG avidity.
.6. Statistical analyses
Statistical analyses were performed using GraphPad Prism
oftware package 5.0 (GraphPad Software Inc., San Diego, USA).
omparison of AI values among study groups were done by using
he Mann–Whitney (U) test and comparison of frequency of AI
esults was analyzed by the Fisher exact test. Probability (P) val-
es < 0.05 were regarded as statistically signiﬁcant.
. Results
As shown in Fig. 1, avidity index was higher in sera from G2
han G1 in each serum dilution tested and mean AI (P < 0.05).
he best screening AI corresponded to serum dilution of 1:160, in
hich was observed the highest differentiation between G1 and G2
atients. At this dilution point, AI ranged from 47% to 93% (median
8%) in G1 sera, and from 47% to 175% (median 88%) in G2 sera
P < 0.0001).
It  was also observed that an AI value of 75% could be estab-
ished to better differentiate groups 1 and 2, sera with AI < 75%
ere predominantly found in G1, whereas sera with AI > 75% were
igniﬁcantly detected in G2 patients (P < 0.0001) (Table 1).
Comparison between screening AI (serum dilution of 1:160)
nd mean AI of different serum dilutions that had a positive result
howed no signiﬁcant difference in each group (P > 0.05) (Fig. 2).
Avidity immunoblot assays were performed to complement
vidity ELISA data, especially in cases with discrepant cut-off
AI = 75%). Analysis was conducted with ten serum samples, ﬁve
rom each group. An example of software image analysis to iden-
ify bands and to evaluate intensity of recognition before and after
itive patients with larval output (G1) or undetectable larvae in stool specimens
(G2). Dashed line indicates threshold for differentiation between groups (AI = 75%).
Horizontal bar indicates the median. Statistical signiﬁcance was calculated by the
Mann–Whitney test (*P < 0.0001). n: number of samples analyzed in each condition.
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Fig. 3. Avidity immunoblot analysis of reaction intensity and antigenic bands identiﬁcation of saline extract of Strongyloides venezuelensis larvae (SE). Peaks of intensity,









(ndicative of the bands detected were generated by ImageJ version 1.44. IgG avidity
U+) with untreated sample (U−). Serologically positive patients with larval output 
reatment with urea is shown in Fig. 3. Panel sera recognized eight
ntigenic bands: 120–160, 65–70, 52–55, 45, 41, 35–28, 21 and
9 kDa (Fig. 4). Avidity of IgG anti-Strongyloides for each band recog-
ized are summarized in Table 2. Sera from G1 patients with ELISA
creening and/or mean AI > 75% showed high decrease in reactiv-
ig. 4. IgG avidity immunoblot anti-Strongyloides venezuelensis saline extract using serum
erologically positive patients with larval output (G1) or negative in parasitological tests
MW)  in kilodaltons (kDa) of antigenic proﬁle recognized. components was  calculated by comparing reactivity decrease of strip urea treated
r negative in parasitological tests (G2).
ity. The high decrease in intensity of at least two  bands (except
case 4 who  recognized only one band) classiﬁed G1 samples as low
avidity (−, +). Conversely, in G2, samples showed AI < 75% with low
decrease in bands intensity, being assessed as high avidity (++, +++)
ones.
 samples discrepant of the avidity ELISA index threshold established (AI = 75%) from
 (G2). Sample submitted to 6 M urea treatment (U+) or not (U−). Molecular weight
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Table 2
IgG avidity pattern in ELISA and immunoblot reactions with Strongyloides venezuelensis antigens in ten cases discrepant of the avidity ELISA index cut-off (AI = 75%) in
serologically positive patients with larval output (G1) or undetectable larvae in stool specimens (G2) tested in the immunoblot.
Cases ELISA Immunoblot
Avidity index (%) Decrease in intensity of recognitionb
Screeninga Mean MW  (kDa)
120–160 65–70 52–55 45 41 35–28 21 19
G1
1 92.7 103.1 − − − − − − − −
2 87.8  91.4 +++ +++ − − − +
3  84.9 89.3 − + ++ − − +++ ++
4  100.2 −
5 89.8 85.4 − ++ + +++ +++
G2
1 74.9 80.2 ++ ++ +++ +++
2 71.4  74.0 ++ +++ ++ +++ +++ +++
3  69.6 71.3 +++ +++ +++ ++ ++ +++
4  68.7 79.0 +++ ++ +++ ++ ++ +++
5  46.9 46.2 +++ ++ +++ +++







































la Screening AI was  calculated based on the screening serum dilution of 1:160.
b Decrease in intensity of recognition categories: − or + low avidity bands indicat
ow  decrease in intensity of recognition.
. Discussion
Currently diagnosis of human strongyloidiasis depends primar-
ly on the detection of larvae in stool and also by the detection
f speciﬁc antibodies in serum. However, antibody levels cannot
ifferentiate between active infection and suspect cases or false
ositive serological results. Furthermore, immunodiagnostic tests
re not able to distinguish cases with positive coproparasitological
ests from those with negative stool examination for S. stercoralis
arvae but with positive serology. For that reason there is no estab-
ished ideal screening strategy [26,27].
Serological assays as ELISA for detection of serum antibodies
gainst the pathogenic intestinal nematode S. stercoralis comple-
ent parasitological tests to detect larvae in stool, and represent
 useful tool for laboratory evaluation of risk patients, such as
mmunocompromised ones [4].  Several studies conﬁrmed that
etection of positive cases is improved when both techniques are
sed [6,7,26,28,29].
Avidity testing provides robust epidemiological data when used
o analyze groups, but interpretation of avidity results for any
atient is less certain because of individual variation [30,31]. Thus,
alculating avidity index as screening AI and mean AI at different
ositive serum dilutions can reduce potential differences in avidity
ue to antibody response intensity and concentration in each sam-
le. This allows determination of individual avidity status [32,33].
The determination of antigens recognized in immunoblot by
igh and low avidity antibodies, has been suggested to toxoplas-
osis [14] and schistosomiasis [34]. Comparative results between
LISA and immunoblot suggest complementary interpretations,
nal criterion of avidity in immunoblot follows the ELISA proﬁle
utlined in order to separate groups (G1 AI < 75% and G2 AI > 75%).
ome individuals in G2 revealed no high avidity antibodies in ELISA
uring phase without elimination of larvae in feces, but revealed
ands with high avidity antibody bounded. Conversely, G1 patients
ith high ELISA AI had a high decrease in intensity of at least two
ands, deﬁned as low avidity sample. Those data can be explained
y different principles of each technique. Avidity immunoblot used
nly one serum dilution point and has a quality principle; thus, blot
esults should be cautiously interpreted [11].However, immunoblot signals its ability as a complementary
ool for identifying major antigens responsible for afﬁnity matu-
ation as already seen for other parasitic diseases [11,35]. Among
arval antigens of S. venezuelensis, no differential marker of G1 andhigh decrease in intensity of recognition. ++ or +++ high avidity bands indicated by
G2 were found, although components ranging between 120 and
160 kDa may  be candidates for a new ELISA avidity protocol to
detect S. stercoralis active infection cases. Those antigens indicated a
key involvement in afﬁnity maturation that could reduce individual
variations related to secondary antigens.
Our data reﬂect that IgG avidity assays have an inherent
problem. IgG response maturation after primary infection, as
determined by binding capacity (AI) varies considerably among
individuals [13,15].  Thus, for each considered infection is impor-
tant to assess immunological particularities. Explanation may  lie
in differences between infection severity, larval output rate, para-
site and host interactions, and environmental factors [36], avidity
ﬂuctuations [11] and IgG subclasses differential avidity maturation
[16,17].
Serological avidity tests are known to discriminate between
acute and chronic infection mainly for protozoan parasites, such as
Toxoplasma gondii [30,37,38].  Considering toxoplasmosis authors
suggested that IgG avidity is a valuable marker of recent infec-
tion, a low IgG avidity does not always identify a recently acquired
infection in immunocompetent patients, but high IgG avidity can
exclude primary infections. In this context, we  suppose that high
avidity indexes found in sera of G2 could exclude an active or recent
infection with S. stercoralis. In addition, can be hypothesized that a
previous contact with S. stercoralis followed by natural eradication
or antihelmintic treatment, and a constant antigenic exposure in
the study hyperendemic area lead to antibody afﬁnity maturation
and consequently higher IgG avidity indexes in patients with no
larvae in feces (G2).
Evaluating usefulness of diagnostic tests, Sackett and Haynes
[39] proposed that four phases of questions should be answered.
ELISA to detect strongyloidiasis, according to Speare and Durrhein
[40] is at phase II: Are patients with positive results more likely to
have S. stercoralis infection than patients with a negative or bor-
derline result? The present study using avidity principle permits
the use of ELISA test for strongyloidiasis detection close to phase
III (Does the test distinguish patients with and without the dis-
ease among patients suspected to have the disease?) differentiating
active infection from those suspect or false positive cases.
Strongyloidiasis lacks a gold standard for its diagnosis which
creates a troublesome situation, as most studies use the
coproparastiological examination as gold standard [41]. Stool tests
have lower sensitivity in diagnosis of chronic strongyloidiasis
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nclear [42]. Based on data presented here, IgG avidity ELISA has the
bility to detect active infection. Our protocol proved to be a useful
iagnostic tool in strongyloidiasis diagnosis as well as in seroepi-
emiologic studies, in cases where prior contacts could confound
nterpretation of standard IgG serological assays. In conclusion, the
esults suggest that measurement of speciﬁc IgG avidity may  assist
n clinical discrimination between active infection with S. stercoralis
nd suspect or serological false positive cases.
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